IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19-Reference-Cited by-同舟云学术

IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19

Published:2020-11 Issue: Volume:144 Page:109935
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Leija-Martínez José J.,Huang Fengyang,Del-Río-Navarro Blanca E.,Sanchéz-Muñoz Fausto,Muñoz-Hernández Onofre,Giacoman-Martínez Abraham,Hall-Mondragon Margareth S.,Espinosa-Velazquez Dario

Publisher

Elsevier BV

Subject

General Medicine

Reference46 articles.

1. World Health Organization. WHO Director- General’s opening remarks at the media briefing on COVID-19 -11 March 2020. [internet] [Accessed April 15, 2020]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

2. World Health Organization. Obesity and overweight. [internet] [Accessed April 15, 2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

3. Obesity pandemic: causes, consequences, and solutions-but do we have the will?;Meldrum;Fertil Steril.,2017

4. Obesity and severe obesity forecasts through 2030;Finkelstein;Am J Prev Med.,2012

5. Immunological complications of obesity;Kanneganti;Nat Immunol.,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Eﬀect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications;General Reanimatology;2024-09-06

2. Developing a predictive nomogram for mortality in patients with extrapulmonary acute respiratory distress syndrome: the prognostic value of serum soluble thrombomodulin, lung ultrasound score, and lactate;Frontiers in Pharmacology;2024-08-27

3. Studying the correlation of inflammatory cytokines to COVID-19 disease;Pathology - Research and Practice;2024-03

4. Evaluation of the serum levels of CCL2, CCL3, and IL-29 after first and second administrations of the COVID-19 vaccine (Oxford–AstraZeneca);Immunobiology;2024-03

5. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30